FAP and cancer: Despite significant advances in research on FAP as an anti-cancer target candidate with broad clinical application prospects in conjunction with checkpoint blockade immunotherapy of solid tumors, the potentiality of lethal adverse effects should be taken into consideration when targeting FAP for immunotherapeutic purposes.